Építés alatt – nem éles oldal
Belépés

Krónikus mieloid leukémia (CML) trials, also abroad

190 open Krónikus mieloid leukémia (CML) trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

OrszágOpen trials
Egyesült Államok100
Franciaország29
Kína21
Németország19
Olaszország19
All other countries

The same trial often runs in several countries

Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia has 1 site in Svédország and runs in 8 countries. If a site near you is full, another one may still take people.

See Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia in all 8 countries
Építés alatt, nem éles – Krónikus mieloid leukémia (CML): vizsgálatok itt: Svédország – Frontlight Research